Hi — I handle bulk & wholesale for this oil. Ask me anything, or tap a question below.
What the research says
More than a carrier. And we cite every word.
People reach for Moringa for more than one thing. Here’s what the published studies actually found — graded honestly, each one linked.
12
uses studied
17
papers cited
0
hidden from you
What the published studies found
Early evidence · 3 studies
Joint Inflammation
Available evidence consists mainly of a narrative review discussing Moringa oleifera's general anti-inflammatory and immunomodulatory properties, including brief mention of rheumatoid arthritis, but no dedicated clinical trials on joint inflammation were found in these results.
A narrative review notes moringa is marketed for moisturizing/antioxidant skincare benefits but lacks standardized formulation and clinical trial data, while a lab-based formulation study demonstrated antimicrobial and anti-inflammatory activity of a moringa seed oil cream without testing on human dry skin.
Evidence is limited to animal (mouse) models of neuropathic pain and in-vitro/isolated compound studies showing antinociceptive and anti-inflammatory activity of Moringa oleifera extracts and root-derived compounds; no human clinical trials for muscle pain were found.
Only animal studies exist: Moringa oleifera seed oil enhanced pentobarbital-induced sleep in mice via GABAergic mechanisms, and leaf extract showed CNS depressant effects in mice, but no human clinical trials on sleep/insomnia were found.
A single narrative review mentions Moringa oleifera's anti-acne potential among many other dermatological uses, but this is based on compiling traditional uses and general phytochemical/pharmacological properties rather than clinical trials specifically testing Moringa for acne.
The only clearly relevant study found is an animal experiment showing Moringa oleifera seed powder improved age-related vascular endothelial dysfunction in rats, which relates to systemic vascular aging rather than skin aging/wrinkles; no human or dermatological studies were identified.
The main identified study shows Moringa oleifera leaf extract improved wound contraction, reduced epithelization time, and increased antioxidant enzyme activity and VEGF/TGF-β1 expression in an infected excision wound rat model, but this is a single animal study without human clinical trials.
A single animal study found that a Moringa oleifera seed extract-loaded microemulsion hydrogel reduced atopic dermatitis-like symptoms, IgE levels, and inflammatory cytokines in a DNCB-induced mouse model, but no human clinical trials exist for eczema.
Evidence for Moringa oleifera against fungal infection is limited to in-vitro studies, such as one showing antifungal activity of a leaf extract and derived bismuth nanoparticles against Candida and Aspergillus species; no clinical trials in humans were found.
Only in-vitro/in-silico evidence exists showing Moringa oleifera leaf extract (via rutin) inhibits mushroom tyrosinase comparably to kojic acid, suggesting potential anti-pigmentation activity; no human or animal studies have tested Moringa for hyperpigmentation.
One preclinical study identified three Moringa oleifera seed compounds (niazirin, marumoside A, sitosterol-3-O-β-d-glucoside) that suppressed Th17-related cytokines in vitro and ameliorated TPA-induced psoriasis-like skin lesions in mice, but no human clinical trials exist.
Only one narrative review was identified, mentioning Moringa oleifera's immune-modulatory effects and potential benefit for atopic dermatitis and irritant-induced immune responses, but no clinical trials specifically testing Moringa for rash or contact dermatitis were found.
